Ciltacabtagene autoleucel Not Yet Recruiting Phase 1 Trials for Extramedullary Myeloma Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Not Yet Recruiting | Treatment | 1 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT05666700 | CAR-T Cell Therapy in RelApsed/Refractory Myeloma With ExtrameduLlary Disease - an in Vivo Imaging and Molecular Monitoring Study |